Livongo Health, Inc. Common Stock
LVGO
LVGO was delisted on the 29th of October, 2020.
0 hedge funds and large institutions have $0 invested in Livongo Health, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 388 closing their positions.
100% less funds holding
Funds holding: 391 → 0 (-391)
100% less funds holding in top 10
Funds holding in top 10: 27 → 0 (-27)
100% less capital invested
Capital invested by funds: $7B → $0 (-$7B)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 388
Top Buyers
Top Sellers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$734M |
| 2 |
BlackRock
New York
|
-$554M |
| 3 |
Morgan Stanley
New York
|
-$427M |
| 4 |
HI
HBK Investments
Dallas,
Texas
|
-$390M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$372M |
LVGO Hedge Fund Activity: Q4 2020 in Review
0 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Livongo Health, Inc. Common Stock (LVGO) for Q4 2020, worth a combined $0 — down 100% from $7B a quarter earlier.
Sellers outnumbered buyers: 388 funds closed out of LVGO and 0 opened new positions — a net loss of 388 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Vanguard Group, exiting entirely with an estimated $734M sold.
- 0 institutional investors held Livongo Health, Inc. Common Stock (LVGO) as of Q4 2020, down from 391 in Q3 2020.
- Funds reported $0 of Livongo Health, Inc. Common Stock stock for Q4 2020, down 100% quarter-over-quarter.
- 0 funds opened new Livongo Health, Inc. Common Stock positions in Q4 2020 and 388 closed out, a net change of -388 holders.
- The largest Livongo Health, Inc. Common Stock seller in Q4 2020 was Vanguard Group, an estimated $734M sold.
Based on aggregated 13F filings for Q4 2020.